During the past decade, Arthritis Center of Connecticut conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 1 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Arthritis Center of Connecticut" #1 collaborator was "The Cleveland Clinic" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Arthritis Center of Connecticut" are "Arthritis, Rheumatoid" (1 trials), "Chronic Low Back Pain" (1 trials), "Osteoarthritis" (1 trials) and "Rheumatoid Arthritis" (1 trials). Many other conditions were trialed in "Arthritis Center of Connecticut" in a lesser frequency.

Most popular intervention types in "Arthritis Center of Connecticut" are "Drug" (4 trials). Other intervention types were less common.

The name of intervention was led by "Buprenorphine transdermal delivery system" (1 trials), "Buprenorphine transdermal patch" (1 trials), "HuMax-CD4" (1 trials), "Ibuprofen" (1 trials) and "Naproxen" (1 trials). Other intervention names were less common.

The vast majority of trials in "Arthritis Center of Connecticut" are 4 trials for "All" genders.

Currently, there are NaN active trials in "Arthritis Center of Connecticut". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Arthritis Center of Connecticut, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Arthritis Center of Connecticut, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".